Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 4 2Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1

Conditions

Peripheral Nervous System Diseases 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Insulin Resistance 1Burns 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Fenofibrate × Clear all
NCT07025005 2025-11-04

VRd MM Fibrate

Tanta University

Phase 4 Recruiting
44 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Peripheral Nervous System Diseases

NCT01574131 2019-11-29

Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients

The University of Texas Medical Branch, Galveston

Phase 4 Terminated
3 enrolled

Burns, Insulin Resistance, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡